Athersys (NASDAQ:ATHX) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report sent to investors on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance NASDAQ:ATHX opened at $0.31 on Friday. The business’s fifty day moving average price is $0.54 and its 200 day moving average […]